Clinical Trials Sponsored by Xun Xu

Total 3903 results

Sun Yat-sen University

Not yet recruiting

Umbrella Biomarker-Guided Therapy in NPC

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Recruiting

Adalimumab Plus Methotrexate for the Treatment of Pediatric Uveitis

Uveitis

China
Sun Yat-sen University

Recruiting

Toripalimab Combined With CAV/IE Regimen

Soft Tissue Sarcoma

China
Sun Yat-sen University

Recruiting

Neoadjuvant Carilizumab and Apatinib for Recurrent High-Grade Glioma

Neoadjuvant Therapy | Apatinib | Carilizumab | Recurrent High-Grade Glioma

China
Sun Yat-sen University

Recruiting

Chidamide With Immunotherapy for Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Bladder Cancer Stage IV

China
Sun Yat-sen University

Recruiting

Study of Therapeutic Value of Periorbital Injection of Glucocorticoid in Mild TAO

Thyroid Associated Ophthalmopathy

China
Sun Yat-sen University

Not yet recruiting

Camrelizumab Combined With Apatinib in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Recruiting

Safety and Efficacy of PEG-rhG-CSF in Preventing Neutropenia in Children With Tumor After Chemotherapy

Pediatric Cancer

China
Sun Yat-sen University

Recruiting

Study of Radiotherapy Combined With Albumin Bound Paclitaxel and Nedaplatin for Locally Advanced NSCLC

Non-small Cell Lung Cancer

China
Sun Yat-sen University

Recruiting

Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial

Hypopharyngeal Cancer

China
Sun Yat-sen University

Recruiting

GM1 Prophylaxis for WBRT Related Cognitive Dysfunction (GLORY)

Breast Cancer | Cognitive Impairment | Brain Metastases | Radiotherapy Side Effect | Gangliosidosis, GM1

China
Sun Yat-sen University

Recruiting

mFOLFOXIRI Versus mFOLFOX6 as Adjuvant Chemotherapy for Locally Advanced Colorectal Cancer (FANTASTIC)

Colorectal Cancer

China
Sun Yat-sen University

Recruiting

Chidamide Combination With Lenalidomide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Relapsed or Refractory Peripheral T-cell Lymphoma

China
Sun Pharmaceutical Industries Limited

Recruiting

Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)

Active Psoriatic Arthritis

United States, Australia, Czechia, Estonia, Korea, Republic of, Poland, Slovakia, Spain, Taiwan, Germany, Italy, India, Canada
Sun Yat-sen University

Recruiting

Thoracic Re-irradiation For Locoregionally Recurrent Non-small Cell Lung Cancer

Loco-regionally Recurrent NSCLC After Thoracic Radiotherapy

China
Sun Yat-sen University

Not yet recruiting

Pyrotinib in Breast Cancer Patients With Poor Response to the Neoadjuvant Treatment of Trastuzumab and Pertuzumab (PRETTY)

Breast Cancer

China
Sun Yat-sen University

Recruiting

China Q Cohort Study

Hemodialysis | Peritoneal Dialysis | End Stage Renal Disease on Dialysis

China
Sun Yat-sen University

Recruiting

Neo-TACE-HAIC for PVTT-HCC (NeoconceptC)

Hepatocellular Carcinoma | Portal Vein Thrombosis

China
Sun Yat-sen University

Recruiting

HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial

Hepatocellular Carcinoma

China
Sun Yat-sen University

Recruiting

Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma, Nasal Type

NK/T Cell Lymphoma Nos

China
Sun Yat-sen University

Recruiting

RFA Versus SBRT for Recurrent Small HCC

Hepatocellular Carcinoma

China
Sun Pharmaceutical Industries Limited

Recruiting

Safety Study for Prospective Assessment of Pregnancy Outcomes in Patients Treated With Tildrakizumab

Pregnancy Related

United States
Sun Yat-sen University

Not yet recruiting

Effects of Structured Simplified Short-term Intensive Insulin Therapy on Long-term Glycemic Remission

Newly Diagnosed Type 2 Diabetes | Simplified Short-term Intensive Insulin Therapy | Glycemic Remission

China
Sun Yat-sen University

Recruiting

Toripalimab With or Without Celecoxib as Neoadjuvant Therapy in Resectable dMMR/MSI-H Colorectal Cancer (PICC)

Colorectal Cancer | Neoadjuvant Therapy | Mismatch Repair-deficient (dMMR) | Microsatellite Instability-high (MSI-H)

China
Sun Yat-sen University

Recruiting

PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients

Recurrent Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Recruiting

TACE With Lenvatinib Versus Lenvatinib Alone in in First-line Treatment of Advanced HCC (TACE)

Advanced Hepatocellular Carcinoma

China
Sun Yat-sen University

Recruiting

Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC (NIBCUN)

Lung Cancer Stage III

China
Sun Yat-sen University

Recruiting

Toripalimab as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors

Solid Tumor | Advanced Cancer

China
Sun Yat-sen University

Recruiting

TACE-HAIC vs. HAIC for Potentially Resectable HCC

Hepatocellular Carcinoma | Potentially Resection

China
Sun Yat-sen University

Recruiting

A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTients (SMART)

Breast Cancer

China
Sun Yat-sen University

Recruiting

A Trial Comparing Adjuvant Chemotherapy With Observation After Concurrent Chemoradiotherapy of Cervical Cancer (With Pelvic or Para-aortic Node Involvement)

Cervical Cancer | Adjuvant Chemotherapy | Lymph Node Metastases | Radiation

China
Sun Yat-sen University

Not yet recruiting

Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Recruiting

Study of Chidamide as a Single-agent Treatment for Patients With Relapse or Refractory B-NHL

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma (NHL)

China
Sun Yat-sen University

Recruiting

Comparison of Minimal Invasive Lens Surgery and Traditional Cataract Surgery

Congenital Cataract

China
Sun Yat-sen University

Recruiting

A Trial Comparing Observation With Radiation on Pelvic Lymphocysts After Radical Hysterectomy of Cervical Cancer

Cervical Cancer | Radiation Therapy | Lymphocyst

China
Sun Yat-sen University

Recruiting

High Quality Evidence of Chinese Lupus Nephritis (HELP)

Lupus Nephritis

China
Sun Yat-sen University

Recruiting

Prognostic Analysis of Concurrent Chemoradiotherapy With/Without Adjuvant Chemotherapy for Locally Advanced NPC Patients

Local Advanced High Risk Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Recruiting

Study of Surgical Treatment Versus Observation in Children With Moderate Intermittent Exotropia (SOMIX)

Moderate Intermittent Exotropia

China
Sun Yat-sen University

Recruiting

The New Serial Treatment of Temporomandibular Disorders

Temporomandibular Disorder

China
Chong Kun Dang Pharmaceutical

Completed

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fasting Conditions

Endocrine, Nutritional and Metabolic Diseases

Korea, Republic of
Sun Yat-sen University

Active, not recruiting

Treatment Adherence And Influencing Factors in Children With Helicobacter Pylori Infection During Eradication Therapy

Helicobacter Pylori Infection | Children, Only

China
Sun Yat-sen University

Active, not recruiting

Influencing Factors and Trigger Mechanism of Relapse in Expectant Fathers Who Quit Smoking

Smoking Cessation

China
Sun Yat-sen University

Completed

A Clinical Trial of Extraperitonealization for Prevention of Parastomal Hernia After Ileal Conduit

Bladder Cancer

China
Sun Yat-sen University

Completed

Effects of Breast Milk Simulated Infant Formula

Breast Milk | Infant Formula

China
Sun Yat-sen University

Active, not recruiting

PD-1 Antibody Versus Best Supportive Care After Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma (DIPPER)

Nasopharyngeal Neoplasms

China
Chong Kun Dang Pharmaceutical

Active, not recruiting

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D956 in Healthy Adults

Hypertension

Korea, Republic of
Sun Yat-sen University

Completed

Split-course Hypofractionated Radiotherapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378

Type II Diabetes

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150

Diabetes type2

Korea, Republic of
Sun Yat-sen University

Completed

TACE Plus Sorafenib Versus TACE Alone for Recurrent Intermediate Hepatocellular Carcinoma (TREAT)

Hepatocellular Carcinoma | Sorafenib | Transarterial Chemoembolization

China

3

Subscribe